A detailed history of Invesco Ltd. transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 13,708 shares of SERA stock, worth $58,807. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,708
Previous 592,197 97.69%
Holding current value
$58,807
Previous $4.62 Million 97.45%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$6.03 - $8.83 $3.49 Million - $5.11 Million
-578,489 Reduced 97.69%
13,708 $118,000
Q3 2024

Nov 12, 2024

BUY
$5.29 - $8.43 $3.06 Million - $4.88 Million
578,877 Added 4345.92%
592,197 $4.62 Million
Q2 2024

Aug 13, 2024

SELL
$5.6 - $11.69 $3.41 Million - $7.11 Million
-608,514 Reduced 97.86%
13,320 $78,000
Q1 2024

May 14, 2024

BUY
$5.05 - $10.0 $3.14 Million - $6.22 Million
621,834 New
621,834 $5.66 Million

Others Institutions Holding SERA

About SERA PROGNOSTICS, INC.


  • Ticker SERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 29,596,900
  • Market Cap $127M
  • Description
  • Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...
More about SERA
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.